|
|
| 30 Apr 2026 | 18:04 IST |
|
ICICI Pru P.H.D Fund (G) |
|
|
|
|
|
|
|
| NAV Details |
| NAV Date : |
29-Apr-26 |
| NAV [Rs]: |
39.81 |
| Buy/Resale Price [Rs] : |
0.00 |
| Sell/Repurchase Price [Rs] : |
0.00 |
| Max Entry Load % : |
0.00 |
| Max Exit Load % : |
0.00 |
|
|
|
|
|
|
|
|
| Quantum of Dividend % |
NA |
NA |
| Date |
NA |
NA |
|
|
|
|
|
|
| Tax benefits : |
|
| Min. Investment(Rs.) : |
5000 |
| Increm.Investment(Rs.) : |
1000 |
|
|
|
|
|
| Statistical Ratios |
What
is Beta ?
Beta is a measure of the volatility of the portfolio to that of the index. In
simple words it shows the movement of the portfolio in comparison. The Higher
the Beta, higher the volatility of the scheme to the index. If its greater
than1 , then the portfolio is highly volatile to the movemnts in the index. If
the beta is lesser than 1 , then scheme is less volatile to the index and beta
which is close to 1 implies that the scheme is closely following the index.
|
| 0.8153 |
4.7266 |
1.0405 |
16.6171 |
-0.0045 |
|
|
|
|
Sun Pharma.Inds.
|
12.11
|
|
Cipla
|
9.23
|
|
Mankind Pharma
|
7.01
|
|
Biocon
|
6.08
|
|
Dr Reddy's Labs
|
5.97
|
|
Divi's Lab.
|
5.91
|
|
Lupin
|
4.09
|
|
Alkem Lab
|
3.52
|
|
Syngene Intl.
|
3.52
|
|
Aurobindo Pharma
|
3.30
|
|
Cohance Life
|
3.18
|
|
Medplus Health
|
2.73
|
|
Alivus Life
|
2.44
|
|
Zydus Lifesci.
|
2.03
|
|
Entero Healthcar
|
1.90
|
|
J B Chemicals &
|
1.90
|
|
Akums Drugs
|
1.83
|
|
Thyrocare Tech.
|
1.74
|
|
Alembic Pharma
|
1.62
|
|
Gland Pharma
|
1.55
|
|
Pfizer
|
1.35
|
|
Metropolis Healt
|
1.26
|
|
Medi Assist Ser.
|
1.14
|
|
Blue Jet Health
|
1.13
|
|
Anthem Bioscienc
|
1.06
|
|
Fine Organic
|
1.06
|
|
Windlas Biotech
|
1.00
|
|
Sanofi Consumer
|
0.98
|
|
Hikal
|
0.93
|
|
Aarti Drugs
|
0.93
|
|
Glenmark Pharma.
|
0.79
|
|
Senores Pharma.
|
0.76
|
|
Shilpa Medicare
|
0.75
|
|
Astrazeneca Phar
|
0.72
|
|
FDC
|
0.62
|
|
Laxmi Dental
|
0.56
|
|
SPARC
|
0.48
|
|
Nephrocare Healt
|
0.44
|
|
TBILL-91D
|
0.03
|
|
TREPS
|
2.68
|
|
Net CA & Others
|
-0.33
|
|
Cash Margin - Derivatives
|
0.01
|
|
|
|
|
|
|
Asset Allocation
|
|
|
|
 |
|